Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression.

Area of Science:

• Genetics
• Neuroscience
• Molecular Biology

Background:

• Huntington's disease (HD) is a fatal neurodegenerative disorder.
• It stems from a CAG repeat expansion in the HTT gene, producing toxic mutant huntingtin protein.
• Current treatments for HD are limited, highlighting the need for novel therapeutic approaches.

Purpose of the Study:

• To develop and evaluate a new class of CAG repeat-targeting silencing reagents.
• To assess the allele and gene selectivity of these novel reagents.
• To investigate the therapeutic potential of inhibiting mutant huntingtin allele expression.

Main Methods:

• Designed self-duplexing CUG repeat-targeting short interfering RNAs (siRNAs).
• Induced self-duplex formation via U-base substitutions.
• Tested siRNA efficacy and selectivity in patient-derived cells via transfection.
• Evaluated short hairpin RNA (shRNA) vectors for sustained gene silencing.

Main Results:

• Developed novel self-duplexing CUG repeat siRNAs with distinct activity profiles.
• Achieved high allele selectivity, differentiating between normal and mutant HTT alleles.
• Demonstrated significant gene selectivity, distinguishing HTT transcripts from those with shorter CAG repeats.
• Confirmed the use of the RNA interference pathway for gene silencing.
• Showed comparable efficacy and selectivity using shRNA vectors for durable silencing.

Conclusions:

• Self-duplexing CUG repeat siRNAs represent a promising therapeutic strategy for Huntington's disease.
• These reagents offer high selectivity for targeting mutant HTT alleles.
• RNA interference mediated by these novel reagents can effectively reduce mutant huntingtin expression.